Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe long-term side effects of Wegovy (semaglutide) most commonly discussed in clinical evidence include persistent gastrointestinal symptoms, gallbladder disease, and — in a small number of people — pancreatitis. Most side effects are more pronounced in the early weeks of treatment and settle over time, though some deserve ongoing monitoring. These are prescription-only medicines, and a prescriber assesses your individual risk profile before any treatment begins. The picture is more nuanced than a simple list, so what follows covers what the evidence actually shows, what warrants urgent attention, and what remains less certain over very long timeframes.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The side effects people ask about most when they're further into treatment are gastrointestinal ones: nausea, loose stools, reflux, and a persistent change in appetite. For many, these are front-loaded, the worst of the nausea comes in the first four to eight weeks, particularly after a dose step up, and then fades. But a meaningful minority find that low-level nausea or reflux becomes their new baseline, especially at higher maintenance doses. If you're wondering how Wegovy side effects tend to evolve across the full treatment journey, that page spans the whole spectrum, and longer-term GI symptoms are the part that most commonly leads people to discuss whether the dose is right for them.
Fatigue and headaches also feature in longer-term use, though these are harder to separate from the effect of eating substantially less. Injection-site reactions (mild skin irritation at the weekly injection point) can recur throughout treatment in some people. If you want a clear overview of what the side effects of Wegovy are, covering both how common they are and how severe they can get, that page is a useful starting point alongside the NHS medicines page for semaglutide, which lists the full frequency breakdown and is worth bookmarking rather than relying on memory.
One practical reality: many people are on Wegovy for a year or more. That's long enough for effects that felt manageable at month two to become genuinely disruptive at month ten if they haven't resolved. Honest, regular check-ins with your prescriber matter, not just at the start.
Two risks stand out as clinically significant over the longer term: gallbladder disease and pancreatitis.
Gallstones and gallbladder inflammation (cholecystitis) appear at higher rates in people using semaglutide than in those not on it, particularly when rapid weight loss occurs. Rapid loss of body fat changes bile composition in a way that encourages stone formation, this is not unique to Wegovy, but the speed of weight loss on GLP-1 treatment makes it relevant. Symptoms to watch for include sharp pain in the upper right abdomen, especially after eating fatty foods, nausea, and fever.
Pancreatitis is rarer but serious. In January 2026, the MHRA's Drug Safety Update for GLP-1 medicines specifically highlighted acute pancreatitis as a known risk requiring attention, the signal it flagged was severe, persistent stomach pain that may reach through to the back. If you experience that, stop eating and drinking and get medical help the same day. Don't wait to see if it passes.
There is also ongoing discussion in the medical literature about thyroid C-cell effects seen in animal studies, the UK prescribing information recommends caution in anyone with a personal or family history of medullary thyroid carcinoma. This doesn't mean the risk is established in humans, but it's why the history is taken at consultation. For a fuller look at whether long-term Wegovy use carries additional risks, that page goes deeper on the evolving evidence.
Most GI side effects don't need a trip to A&E, they need a conversation with your prescriber about timing, hydration, or whether a dose pause makes sense. But some symptoms do need same-day medical attention. Seek urgent help for:
Severe stomach pain that won't ease and spreads to your back (possible pancreatitis). Upper-right abdominal pain with fever (possible gallbladder inflammation). Persistent vomiting where you can't keep fluids down for more than 24 hours, dehydration on a GLP-1 medicine can strain the kidneys. Signs of a serious allergic reaction: swelling of the face, lips, or throat, difficulty swallowing or breathing. Sudden changes in vision if you have diabetes. Any thoughts of self-harm or a significant low mood that develops or worsens during treatment.
If something feels wrong and you're not sure which category it falls into, contact your prescriber or call 111. Our aftercare team is available seven days a week, get in touch if you have concerns and aren't sure where to turn.
The MHRA's Yellow Card scheme lets patients report suspected side effects directly. It's genuinely useful, it's how the regulator builds its real-world safety picture beyond clinical trials.
Wegovy has been available in the UK since 2023. The longest clinical trial data runs to around 68–72 weeks. That's solid evidence for a medicines trial, but it doesn't tell us with certainty what year five or year ten of use looks like for people who stay on treatment indefinitely.
A few areas sit in the 'watch this space' category. Muscle mass: rapid weight loss on any treatment can reduce lean tissue alongside fat, and the long-term implications of that in people on GLP-1 medicines for years are still being studied. Bone density: some researchers are looking at whether prolonged low calorie intake during treatment has downstream skeletal effects. These aren't established harms, they're active research questions.
What is established is that stopping Wegovy is associated with significant weight regain in most people. The question of very long-term use is therefore partly a question about what ongoing use entails compared to the health consequences of stopping. That's a clinical conversation worth having with a prescriber who knows your full history.
You can read about the side effects of long-term Wegovy use in more depth, including the muscle-mass and bone-density questions, on the dedicated page. And if you're comparing semaglutide's profile to tirzepatide's, the long-term side effects of semaglutide more broadly covers both its weight-loss and diabetes-treatment contexts. At nume, our prescribers discuss exactly this kind of question (what the evidence shows, what's still being studied, and whether treatment is right for you) as part of every consultation. If you'd like to speak to our prescribers about your specific situation, you can start a free consultation today.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.